Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) & Jesus Usón Minimally Invasive Surgery Center (JUMISC) 21 May NANBIOSIS attended MedTech Forum 2026 in Stockholm, strengthening international collaborations and exploring the latest trends in medtech innovation Stockholm, May 2026 — Last week, from 11 to 13 May 2026, NANBIOSIS participated in the MedTech Forum 2026, one of Europe’s leading conferences[...] 20 May Researchers from INMA and NANBIOSIS have developed ultrasmall platinum nanoparticles that significantly boost radiotherapy effectiveness against cancer. Zaragoza, May 2026 — Researchers from the Aragon Nanoscience and Materials Institute (INMA), together with collaborators from Instituto de Salud Carlos III, Spanish National Cancer[...] 21 May NANBIOSIS attended MedTech Forum 2026 in Stockholm, strengthening international collaborations and exploring the latest trends in medtech innovation Stockholm, May 2026 — Last week, from 11 to 13 May 2026, NANBIOSIS participated in the MedTech Forum 2026, one of Europe’s leading conferences[...] 20 May Researchers from INMA and NANBIOSIS have developed ultrasmall platinum nanoparticles that significantly boost radiotherapy effectiveness against cancer. Zaragoza, May 2026 — Researchers from the Aragon Nanoscience and Materials Institute (INMA), together with collaborators from Instituto de Salud Carlos III, Spanish National Cancer[...] 21 May NANBIOSIS attended MedTech Forum 2026 in Stockholm, strengthening international collaborations and exploring the latest trends in medtech innovation Stockholm, May 2026 — Last week, from 11 to 13 May 2026, NANBIOSIS participated in the MedTech Forum 2026, one of Europe’s leading conferences[...] 20 May Researchers from INMA and NANBIOSIS have developed ultrasmall platinum nanoparticles that significantly boost radiotherapy effectiveness against cancer. Zaragoza, May 2026 — Researchers from the Aragon Nanoscience and Materials Institute (INMA), together with collaborators from Instituto de Salud Carlos III, Spanish National Cancer[...]Welcome to Nanbiosis
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ipsa dicta hic cupiditate dolor, aspernatur, blanditiis aperiam omnis corporis voluptatibus aut nihil a quis. Accusamus, numquam, accusantium ipsum itaque quidem expedita. Lorem ipsum dolor sit amet, consectetur adipisicing elit.Latest From the Blog

NANBIOSIS strengthens international collaborations at MedTech Forum 2026

Platinum Nanoparticles Boost Radiotherapy Effectiveness Against Cancer

NANBIOSIS strengthens international collaborations at MedTech Forum 2026

Platinum Nanoparticles Boost Radiotherapy Effectiveness Against Cancer

NANBIOSIS strengthens international collaborations at MedTech Forum 2026

Platinum Nanoparticles Boost Radiotherapy Effectiveness Against Cancer
Units of Nanbiosis

About Nanbiosis
Responsive Design
HiDPi Ready
Drag’n’drop builder





